Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospital discharge than those who had a cardiac arrest in the intensive care unit (ICU), yet less likely to survive than those who had an arrest in the operating room (OR).
This is according to preliminary research to be presented this week at the American Heart Association’s (AHA’s) Resuscitation Science Symposium (ReSS) 2021 a virtual meeting being held in conjunction with AHA’s 2021 Scientific Sessions (13–15 November; virtual).
An estimated 292,000 adults experience in-hospital cardiac arrest each year in the USA, based on recent data from the AHA’s Get With The Guidelines-Resuscitation quality improvement program.
“Cardiac arrest while in the hospital cardiac catheterisation laboratories is likely on the rise due to the increase in complex procedures being done on people at high risk for complications,” said study author Ahmed Elkaryoni, a cardiology fellow at Loyola University Medical Center in Maywood, USA. “There are, however, unanswered questions about cardiac arrest while in the cardiac catheterisation lab, including how common it is compared to other areas of the hospital, characteristics of the cardiac arrest event and what the chances are of survival to discharge. In this study, we compared rates of survival to hospital discharge for people who had in-hospital cardiac arrest while in the cardiac catheterisation lab, versus the OR and ICU.”
Researchers referred to the AHA’s Get With the Guidelines-Resuscitation registry to identify adults ages 18 years and older who had an in-hospital cardiac arrest in the cardiac catheterisation lab, ICU or OR between 2000 and 2019.
The analysis found that across 428 hospitals, 193,950 adults had an in-hospital cardiac arrest. Nearly 6,900 of those were in the cardiac cath lab; nearly 182,000 were in the ICU; and about 5,180 were in the OR. Overall, 38.1% of people who had in-hospital cardiac arrest in the cardiac catheterisation lab survived to discharge, compared to 16.9% in the ICU and 40.5% of people who had a cardiac arrest while in the OR.
Patients who survived a cardiac arrest in the cath lab were more likely to be younger, white adults; have their arrest during normal hours and on weekdays; and initially experience pulseless ventricular fibrillation while in cardiac arrest.
Patients were less likely to survive to discharge after an in-hospital cardiac arrest in the cardiac catheterisation lab if they had any of these factors: experienced a heart attack during this or a prior hospitalisation; had low blood pressure, metabolic or electrolyte abnormalities, or respiratory insufficiency; or required mechanical ventilation.
“Our study shows that in-hospital cardiac arrest in the cardiac catheterisation lab is not uncommon and has a slightly lower survival rate when compared with in-hospital cardiac arrest in the OR,” Elkaryoni said. “The reasons for this difference, however, deserve further study given that cardiac arrest in both settings is witnessed and response time should be similar.”
A study limitation is that while the AHA’s Get With the Guidelines-Resuscitation quality improvement programme is the largest nationwide multicentre registry detailing in-hospital cardiac arrest in the USA, it represents only about 15% of all US hospitals. Therefore, the findings may not be generalisable to hospitals not participating in the registry, Elkaryoni noted.